Naftifine

This classification denotes an antifungal agent with the molecular formula C21H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4FB1TON47A, chemically known as 1-naphthalenemethanamine, n-methyl-n-(3-phenyl-2-propenyl)-, (e)- but generally known as naftifine, which bears US NIH Compound Identifier 47641. European Medicines Agency schedules Naftifine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09131MIG. The term NAFTIFINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules naftifine in its Anatomical Therapeutic Chemical (ATC) Classification. NAFTIFINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naftifine under HS 29214980 and SITC 51454. As of Q4 2014, NAFTIFINE remains the US FDA Preferred Term for this commodity. Naftifine bears US NLM identifiers UMLS ID C0068367 and NCI Concept Code C66217. SMILES: N(CC1C2C(CCC1)CCCC2)(C/C=C/C1CCCCC1)C.